Recap: Concert Pharmaceuticals Q4 Earnings


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


 

Concert Pharmaceuticals (NASDAQ:CNCE) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Here's what investors need to know about the announcement.

Earnings

Concert Pharmaceuticals missed estimated earnings by 38.36%, reporting an EPS of $-1.01 versus an estimate of $-0.73.

Revenue was up $6.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 9.9% increase in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: EarningsNewsBZI-Recaps